Caris Life Sciences, Inc.
CAI- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0002019410
In the last 90 days, Caris Life Sciences, Inc. insiders filed 1 open-market purchase and 3 sales; 247 institutions reported holding it in 13F filings for Q2 2026, worth $2.75B in total; superinvestors Coatue Management and Duquesne Family Office hold it.
Holders of 5% or more of CAI
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Caris Life Sciences, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Halbert David D | 13G | 44.10%124.9M shares | New | Aug 13, 20251 filing | Aug 13, 2025 | SEC |
| FMR LLC | 13G/A | 10.80%30.6M shares | +5.80 ppfrom 5.00% | Feb 5, 20262 filings | Apr 7, 2026 | SEC |
| TSSP Sub-Fund HoldCo LLC | 13G | 8.80%24.4M shares | New | Jul 28, 20251 filing | Jul 28, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
11 Schedule 13D and 13G filings on Caris Life Sciences, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 12, 202612:38 PM ET | J H Whitney VI L Pand 3 others | 13G/A | 4.00%11.3M shares | −2.50 ppfrom 6.50%Below 5% | Jun 30, 2026 | SEC |
| Aug 7, 20264:30 PM ET | TSSP Sub-Fund HoldCo LLCand 1 other | 13G/A | 2.60%7.33M shares | −2.50 ppfrom 5.10%Below 5% | Jun 30, 2026 | SEC |
| May 12, 20264:30 PM ET | TSSP Sub-Fund HoldCo LLCand 1 other | 13G/A | 5.10%14.4M shares | −1.80 ppfrom 6.90% | Mar 31, 2026 | SEC |
| May 12, 202610:47 AM ET | J H Whitney VI L Pand 3 others | 13G/A | 6.50%18.3M shares | −0.80 ppfrom 7.30% | Mar 31, 2026 | SEC |
| Apr 7, 20261:21 PM ET | FMR LLCand 1 other | 13G/A | 10.80%30.6M shares | +5.80 ppfrom 5.00% | Mar 31, 2026 | SEC |
| Feb 13, 20264:30 PM ET | TSSP Sub-Fund HoldCo LLCand 1 other | 13G/A | 6.90%19.4M shares | – | Dec 31, 2025 | SEC |
| Feb 5, 20261:20 PM ET | FMR LLCand 1 other | 13G | 5.00%14.1M shares | New | Dec 31, 2025 | SEC |
| Aug 14, 20254:05 PM ET | J H Whitney VI L Pand 3 others | 13G | 7.30%20.3M shares | New | Jun 30, 2025 | SEC |
| Aug 13, 20254:05 PM ET | Halbert David Dand 1 other | 13G | 44.10%124.9M shares | New | Jun 30, 2025 | SEC |
| Jul 28, 20254:30 PM ET | TSSP Sub-Fund HoldCo LLCand 1 other | 13G | 8.80%24.4M shares | New | Jun 30, 2025 | SEC |
| Jun 24, 20254:39 PM ET | Riverview Group LLCand 3 others | 13G | 1.30%3.58M shares | NewBelow 5% | Jun 17, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Caris Life Sciences, Inc. shares.
No Form 144 notices for Caris Life Sciences, Inc. are on file.